The Office of Research and Sponsored Programs (ORSP) has received an agreement from Gateway Biotechnology, Inc. for funding in the amount of $50,000 to support the project titled “Preclinical Testing of Tetrandrine Against Noise-Induced Hearing Loss.” These funds are pass through federal funds from the National Institutes of Health, National Center for Complementary & Integrative Health.